You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01906528 ↗ Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium Completed Oslo University Hospital Phase 1 2013-03-01 Muscle relaxants are drugs providing muscle relaxation during surgical treatment. Previous studies have shown that males and females respond differently to this kind of drug. Our hypothesis is that males are more sensitive to the effect of Mivacurium (a muscle relaxant) than females, meaning that males need a lower blood concentration of the drug than females in order to obtain a given effect.
NCT01906528 ↗ Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium Completed University of California, San Francisco Phase 1 2013-03-01 Muscle relaxants are drugs providing muscle relaxation during surgical treatment. Previous studies have shown that males and females respond differently to this kind of drug. Our hypothesis is that males are more sensitive to the effect of Mivacurium (a muscle relaxant) than females, meaning that males need a lower blood concentration of the drug than females in order to obtain a given effect.
NCT02117401 ↗ A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients Completed Jiangsu Nhwa Pharmaceutical Co., Ltd. Phase 4 2012-01-01 To evaluate the effect and safety of mivacurium chloride in pediatric patients.
NCT02473601 ↗ Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis Unknown status Jiangsu Nhwa Pharmaceutical Co., Ltd. Phase 2 2014-10-01 Observed the muscle relaxation of mivacurium in patients with liver cirrhosis.Clear of mivacurium in patients with liver cirrhosis without muscle relaxant accumulation and delayed recovery phenomenon
NCT02473601 ↗ Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis Unknown status Tang-Du Hospital Phase 2 2014-10-01 Observed the muscle relaxation of mivacurium in patients with liver cirrhosis.Clear of mivacurium in patients with liver cirrhosis without muscle relaxant accumulation and delayed recovery phenomenon
NCT02664142 ↗ BIS Monitoring of the Depth of Anaesthesia in Children Completed University Hospital Ostrava N/A 2015-06-01 General anaesthesia (GA) is, according to many definitions, the greatest gift presented to the medical art (S. B. Nuland). One of the aims of GA is to achieve the optimal depth of anaesthesia and rapid emergence from general anaesthesia. In order to achieve this goal, it is necessary to observe the clinical condition of the patient, and at the same time monitor the patient's overall condition. With the currently available options of GA management (e.g. use of intravenous anaesthetics, strong analgesics and modern volatile anaesthetics, in combination with various methods of topical anaesthesia) the importance of methods measuring the depth of GA increases. The depth of GA may be defined as a continuous progressive decreasing of the central nervous system, together with a decreased reactivity to stimuli. In the course of GA, perioperative awareness is detected in 0.1-0.2% of cases. Awakening during a surgical procedure may result in significant psychological complications (e.g. post-traumatic stress disorder), and the patient may suffer from a serious long-time disorder.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER

Condition Name

Condition Name for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
Intervention Trials
Anaesthesia 1
Efficacy and Safety of Mivacurium Chloride for Pediatric Patients 1
General Surgery 1
Liver Dysfunction 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
Intervention Trials
Paralysis 1
Liver Diseases 1
Liver Cirrhosis 1
Fibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER

Trials by Country

Trials by Country for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
Location Trials
Czechia 1
Czech Republic 1
China 1
Belgium 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
Location Trials
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
Phase 1 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase Trials
Completed 4
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor Trials
Jiangsu Nhwa Pharmaceutical Co., Ltd. 2
University of California, San Francisco 1
Tang-Du Hospital 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor Trials
Other 5
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.